摘要
目的比较尤瑞克林治疗颈内动脉系统短暂性脑缺血发作的疗效。方法采用随机分组方法,将纳入的52例患者分为治疗组(28例)和对照组(24例),观察两组患者在第2周及3月的复发情况。结果 2周时治疗组未复发比例60%,对照组54%(P=0.016),3月后治疗组未复发比例75%,对照组未复发比例62.5%(P=0.378)。结论尤瑞克林能有效控制急性期颈内动脉系统短暂性脑缺血的发作,但对减少远期复发率不明显。
Objective To compare the curative effect of urinarykallid in the treatment of internal carotid artery system transient ischemic attack. Methods 52 patients were randomly divided into groups treatment group（28 case）and control group（24 case）. Recurrence rate were observed at the second week and the third months. Results At the second week, the no-recurrence rate was 60% in treatment group while that was 54% in the control group（P=0.016）. At the third months, the no-recurrence rate was 75% in treatment groups while that was 62.5% in the control group（P=0.378）. Conclusion Urinarykallid is effective in treating patients with acute phase of TIA. But it has no significant effect in reducing long-term recurrence rate.
出处
《中国卫生标准管理》
2015年第13期149-150,共2页
China Health Standard Management
关键词
尤瑞克林
复发率
TIA
TIA
Urinarykallid
Relapse rate
